title: Case 5-2006: recombinant factor VIIa in the management of postoperative bleeding after repair for inadvertently thrombolysed acute type A aortic dissection.
authors.affiliation: Department of Cardiac Anesthesiology, Aberdeen Royal Infirmary, Aberdeen, Scotland. faber@doctors.org.uk <faber@doctors.org.uk>
authors.forename: Peter
authors.initials: P
authors.lastname: Faber
authors.forename: Colin
authors.initials: C
authors.lastname: Reid
authors.forename: Hussein
authors.initials: H
authors.lastname: El-Shafei
authors.forename: Bode
authors.initials: B
authors.lastname: Falase
authors.forename: Abe
authors.initials: A
authors.lastname: DeAnda
authors.forename: C David
authors.initials: CD
authors.lastname: Mazer
mesh_terms: D000208:Acute Disease; D000784:Aortic Dissection / Q000000981:diagnostic imaging / Q000628:therapy*; D017545:Aortic Aneurysm, Thoracic / Q000000981:diagnostic imaging / Q000628:therapy*; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D005343:Fibrinolytic Agents / Q000009:adverse effects*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D019106:Postoperative Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D011994:Recombinant Proteins / Q000627:therapeutic use; D015912:Thrombolytic Therapy / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed; D014656:Vascular Surgical Procedures / Q000009:adverse effects*
chemical_list: D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa